SAFLUTAN

Details for Australian Trade Mark No. 1328216 (hide)

Owner Merck Sharp & Dohme Corp.

Service Shelston IP

Filing Date 23 October 2009

Classes

Class 5 Pharmaceutical preparations; including ophthalmic preparations for the treatment of glaucoma

Event Publications

19 November 2009 Application filed

25 February 2010 Application Accepted

22 July 2010 Trade Mark Registered/Protected

5 July 2012 Subsequent Owners/Holder Registered - Full Assignment

  Schering Corporation is the full asignee of Merck Sharp & Dohme Corp..

26 July 2012 Registrations/Protected IR Name Amendment and Changes

  The owner's/holder's name has been changed to Merck Sharp & Dohme Corp..

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1328217-BIOORGANICS GLUCOSAMINE RX

1328215